drugset / Trial / NCT01657305
Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12)
RandomizedSingle-groupSingle-blindTreatment
Summary
The main purpose of this phase III clinical trial was to compare intra-individually the efficacy, safety and tolerability of Oleogel-S10 and non-adhesive wound dressing versus non-adhesive wound dressing only in accelerating the wound healing of Split-Thickness Skin Graft (STSG) donor sites.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIRCH TRITERPENES | Small molecule | 100 mg | Topical |
Indications
No indication recorded.